News & analysis on the clinical development and manufacture of large molecule drugs
By Natalie Morrison
- Last updated on
He is working closely with his replacement, Franck Latrille, to ensure a smooth transition process.
Wedlake joined NextPharma CFO in 2000, the same year that it was founded, and was later appointed CEO and board member.
David Finnigan of Sun European Partners, NextPharma's shareholder, said: “I am very grateful to Bill for his considerable contributions to NextPharma over the past eleven years and I wish him every success for the future."